Table 4.4

Surveillance After Aortic Endograft or Aortoiliac Stenting

IndicationAppropriate Use Score (1–9)
Baseline (Within 1 Month After the Intervention)
95.
  • Aortic or iliac endograft

A (8)
96.
  • Aortic and iliac artery stents

A (7)
New or Worsening Lower Extremity Symptoms After Baseline Exam
97.
  • Aortic or iliac endograft

A (8)
98.
  • Aortic and iliac artery stents

A (8)
Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency During First YearAt 3 to 5 monthsAt 6 to 8 monthsAt 9 to 12 months
99.
  • Aortic endograft without endoleak stable and/or decreasing residual aneurysm sac size

I (3)U (5)U (6)
100.
  • Aortic endograft with endoleak and/or increasing residual aneurysm sac size

U (6)A (8)A (7)
101.
  • Aortic or iliac artery stents

I (2)U (5)U (6)
Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency After First YearEvery 6 monthsEvery 12 monthsEvery 24 months or greater
102.
  • Aortic endograft without endoleak stable and/or decreasing residual aneurysm sac size

I (3)A (7)U (5)
103.
  • Aortic endograft with endoleak and/or increasing residual aneurysm sac size

A (8)A (7)U (5)
104.
  • Aortic or iliac artery stents

I (2)U (5)U (5)

A = appropriate; I = inappropriate; U = uncertain.